Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Change in Cash (2016 - 2025)

Historic Change in Cash for Medifast (MED) over the last 16 years, with Q4 2025 value amounting to -$10.2 million.

  • Medifast's Change in Cash rose 5806.64% to -$10.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$1.6 million, marking a year-over-year increase of 5373.01%. This contributed to the annual value of -$1.6 million for FY2025, which is 5373.01% up from last year.
  • Per Medifast's latest filing, its Change in Cash stood at -$10.2 million for Q4 2025, which was up 5806.64% from -$2.2 million recorded in Q3 2025.
  • Medifast's Change in Cash's 5-year high stood at $42.3 million during Q1 2021, with a 5-year trough of -$56.9 million in Q2 2022.
  • Its 5-year average for Change in Cash is -$3.7 million, with a median of $1.9 million in 2024.
  • Within the past 5 years, the most significant YoY rise in Medifast's Change in Cash was 20890.77% (2021), while the steepest drop was 79549.54% (2021).
  • Over the past 5 years, Medifast's Change in Cash (Quarter) stood at -$50.3 million in 2021, then surged by 135.72% to $18.0 million in 2022, then crashed by 201.84% to -$18.3 million in 2023, then plummeted by 33.14% to -$24.4 million in 2024, then skyrocketed by 58.07% to -$10.2 million in 2025.
  • Its Change in Cash stands at -$10.2 million for Q4 2025, versus -$2.2 million for Q3 2025 and $10.0 million for Q2 2025.